Midatech Pharma Aktie
WKN DE: A3D7BE / ISIN: US59564R6099
12.05.2025 15:20:15
|
Biodexa Pharmaceuticals: European Commission Grants Orphan Drug Designation For ERapa
(RTTNews) - Biodexa Pharmaceuticals (BDRX) announced the European Commission has granted Orphan Drug Designation for eRapa in familial adenomatous polyposis. The company said the Phase 3 study of eRapa in FAP is in the final stages of implementation.
"This Orphan Drug Designation is another important step as we move our FAP program forward into a registrational Phase 3 study," said Stephen Stamp, CEO and CFO of Biodexa Pharmaceuticals.
Shares of Biodexa Pharmaceuticals are down 15% in pre-market trade on Monday.
For More Such Health News, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Midatech Pharma PLC (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |